Cardiovascular Pharmacology

Cardiovascular pharmacology laboratory

Our Vision
We are committed to developing safer, disease-modifying therapies that improve outcomes for patients with life-threatening cardiopulmonary diseases.

Why It Matters
Cardiovascular disease remains the world’s leading cause of death. A growing body of evidence points to unresolved, dysregulated inflammation as a key driver of disease progression. Despite this, current treatments often fail to target these underlying mechanisms, leaving a critical gap in care.

Our Approach
At the Cardiovascular Pharmacology Laboratory, we focus on resolution pharmacology—a next-generation strategy that harnesses the body’s natural ability to resolve inflammation. By developing pro-resolving medicines, we aim to shift the treatment paradigm and offer long-lasting benefits in chronic cardiovascular and pulmonary conditions.

What We Strive For
Our goal is to translate cutting-edge discoveries into real-world therapies that extend and enhance the lives of those affected by cardiopulmonary disease.